Hemorrhoids and conservative treatment. Revision of the literature on the use of diosmin and micronizing hesperidin;Malattia emorroidaria e trattamento conservativo. Revisione della letteratura sull'impiego di Diosmina ed Esperidina micronizzate

Minerva Chirurgica

Volumn 54, Issue 12, 1999, Pages 909-916

  La Torre, F ^a   Nicolai, A P ^b   Otti, M ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; COLLAGEN; HISTAMINE; PROSTAGLANDIN; PROTEOGLYCAN;

CONSERVATIVE TREATMENT; HEMORRHOID; HUMAN; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; DIOSMIN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FLAVONOIDS; HEMORRHOIDS; HESPERIDIN; HUMANS; LYMPHEDEMA; MALE; MIDDLE AGED; PLACEBOS; PLATELET AGGREGATION INHIBITORS; PREGNANCY; THROMBOPHLEBITIS; TIME FACTORS;

EID: 0033498175     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Abenhaim L, Norgren L, Clement D, and the VEINES Task Force. The management of chronic venous disorders of the leg: an evidence-based report of an international task force. Phlebology, 1997.
2. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Int Angiol 1988;7(Suppl 2):39-43.
3. Guillot B, Guilhou JJ, de Champvallins M et al. A long-term treatment with a venotropic drug. Results on efficacy and safety of Arvenum 500 in chronic venous insufficiency. Int Angiol 1989;8(Suppl 4):67-71.
4. Barbe R, Amiel M. Pharmacodynamic properties and therapeutic efficacy of Arvenum 500. Phlebology 1992;7(Suppl 2):41-4.
5. Allegra C, Bartolo M jr, Cassiani D, Carioti B. Microlymphography assessment of Arvenum 500 activity in patients with chronic venous insufficiency. International Congress of Lymphology. Madrid, Sept. 22-26, 1997.
6. Amato C. Advantage of a micronized flavonoidic fraction (Arvenum 500) in comparison with a nonmicronized diosmin. Angiology 1994;45;531-6.
7. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997;48:67-9.
8. Callam MJ, Ruckley CV, Harper DR et al. Chronic ulcer of the leg: the clinical history. Br Med J 1987;294:1389-91.
9. Phillips T, Stanton B, Provan A et al. A study of impact of the leg ulcers on quality of life: financial, social and psychologic implications. J Am Acad Dermatol 1994;31:49-53.
10. Franks PJ, Moffatt CCJ, Connolly M et al. Community leg ulcer clinics: effects on quality of life. Phlebology 1994;9:83-6.
11. Guilhou JJ, Dereure O, Marzin L et al. Efficacy of Arvenum 500 in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77-85.
12. Casley-Smith JR, Casley-Smith JR. High-proteins Edemas and the Benzo-Pyrones. Sydney, Australia: Lippincott, 1986.
13. Pecking AP, Guilhou JJ. Current evaluation of lymphoedema and assessment by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Arvenum 500) in the treatment of upper limb lymphoedema. Phlebology 1994:(Suppl 1):26-9.
14. Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Arvenum 500 in the treatment of acute hemorrhoids. Angiology 1994;45(6 pt 2): 566-73.
15. Godeberge P. Arvenum 500 is significantly more effective than placebo in the treatment of haemorrhoids. Phlebology 1992;7(Suppl 2):61-3.
16. Delmont J, Ljungren B et al. Assessment of acceptability and efficacy of Arvenum 500 in the long-term treatment (six months) of haemorrhoids. Int J Clin Practice 1991;7(3):84-6.
17. Eu KW, Seow-Choen F, Goh HS. Comparison of emergency and elective hemorrhoidectomy. Br J Surg 1994;81:308-10.
18. Buls JG, Goldberg SM. Modern management of hemorrhoids. Surg Clin North Am 1978;58:469-78.
19. Ganchrow MI, Mazier WP, Friend WG, Ferguson JA. Haemorrhoidectomy revisited - a computer analysis of 2038 cases. Dis Colon Rectums 1971;14:128-33.
20. Johnstone CS, Isbister WH. Impatient management of piles: a surgical audit. Aust N Z J Surg 1992;62:720-4.
21. Cheng FC, Shum DW, Ong GB. The treatment of second degree haemorrhoids by injection, rubber band ligation, maximal anal dilatation and haemorroidectomy: a prospective clinical trial. Aust N Z J Surg 1981;51:458-62.
22. Goligher J. Surgery of the anus, rectum and colon. 5th edition. London: Bailliere Tindall, 1983.
23. Nivatvongs S. Complications of anorectal and colorectal operations. In: Gordon PH, Nivatvongs S, editors. Principles and Practice of Surgery for the Colon, Rectum and Anus. St. Louis, Missouri: Quality Medical Publishing, 1992:999-1021.
24. Corman ML. Colon and Rectal Surgery. 2nd edition. Philadelphia, Pa: J.B. Lippincott, 1989.
25. Labrid C, Duhault J, Vix C. Pharmacological properties of Arvenum 500. J Intern Med 1987;85(Suppl):30-6.
26. Ho YH, Foo CL, Seow-Choen F, Goh HS. Prospective randomized controlled trial of a micronized flavonoidic fraction to reduce bleeding after haemorrhoidectomy. Br J Surg 1995;82:1034-5.
27. Seow-Choen F, Ho YH, Ang GH, Goh HS. Prospective randomized trial comparing pain and clinical function after conventional scissors excision/ligation versus diathermy excision without ligation of symptomatic hemorrhoids. Dis Colon Rectum 1992;35:1165-9.
28. Hyamas L, Philpot J. Am J Proctol 1970;21:177-93.
29. Percival R. Churchill Livingstone, 1980:114.
30. Merger R, Rosier P, Santarelli J. Med Intern 1972;7: 347-9.
31. Cospite MM, Cospite V. Treatment of haemorrhoids with Arvenum 500. Phlebology 7(Suppl 2):53-6.
32. Buckshee K, Takkar D, Aggernad N. Terapia con flavonoidi micronizzati per il trattamento delle emorroidi interne in gravidanza. Intern J Gynecol Obstetrics 1997;57:145-51.